CRS Regulatory Science Fellowship Opportunity Broad Call
LEARN MORE
Improving the Process of Therapeutic Development
Harvard, MIT, and the FDA have partnered to create a center focused on regulatory science, bringing together a range of scientific disciplines that are applied to assess the quality, safety and efficacy of medicinal products and inform regulatory decision-making throughout the lifecycle of a medicine. Working across academia, industry, and government institutions, the Center promotes regulatory science through research and education programs, uniting stakeholders under a common mission: promoting optimal patient health outcomes through biomedical innovation and the availability of safe and effective diagnostics and treatments.
Featured Publications
The Regulatory Science Fellowship Program
Our fellowship program is affiliated with the FDA and focuses on training the next generation of regulatory science researchers. Learn more about the research our fellows are conducting or explore opportunities and how to get involved in our program.
News, Events, & Updates
Regulatory Science Forum – “The Digital Revolution in Regulated Medical Products: Clinical Trials, Digital Therapeutics, and Regulated AI Devices“
Ariel D. Stern, PhD
December 5th, 2023 | 12pm – 1:00 PM ET
Twitter @Harvardmit_CRS
Congrats to CRS Fellow @ryanpknox on their new piece in @JAMAHealthForum investigating the outcomes of the 340B Drug Pricing Program on the American #healthcaresystem.
@AmeetSarpatwari @akesselheim @wbfeldman
#drugpricing #340B
Read CRS Fellow @ElsallabMagdi new publication! The @NatureBiotech perspective focuses on technical/regulatory challenges and solutions of expanding #CART cell #manufacturing.
@MarcelaMaus #biotechnology #GeneTherapy
How can we enable local #CART cell #manufacturing?
Check out our @NatureBiotech perspective where we dive into technical/regulatory challenges and solutions.
@MarcelaMaus
#biotechnology #GeneTherapy